6534 Stock Overview
CH Biotech R&D Co., Ltd., develops and sells biotech-based agrochemicals in Taiwan, the United States, Canada, Australia, Brazil, Argentina, Uruguay, Chile, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
CH Biotech R&D Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$83.00 |
52 Week High | NT$114.50 |
52 Week Low | NT$71.70 |
Beta | 0.43 |
1 Month Change | -4.05% |
3 Month Change | 0.97% |
1 Year Change | 3.75% |
3 Year Change | 69.24% |
5 Year Change | -11.65% |
Change since IPO | 2.73% |
Recent News & Updates
Recent updates
CH Biotech R&D (GTSM:6534) Takes On Some Risk With Its Use Of Debt
Apr 05A Look At CH Biotech R&D's (GTSM:6534) Share Price Returns
Mar 18Are CH Biotech R&D Co., Ltd.'s (GTSM:6534) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Feb 09Returns On Capital At CH Biotech R&D (GTSM:6534) Paint An Interesting Picture
Jan 11Does CH Biotech R&D (GTSM:6534) Have A Healthy Balance Sheet?
Dec 15Tread With Caution Around CH Biotech R&D Co., Ltd.'s (GTSM:6534) 1.8% Dividend Yield
Nov 24Shareholder Returns
6534 | TW Chemicals | TW Market | |
---|---|---|---|
7D | -0.1% | 1.6% | 2.8% |
1Y | 3.8% | -14.4% | 27.4% |
Return vs Industry: 6534 exceeded the TW Chemicals industry which returned -14.4% over the past year.
Return vs Market: 6534 underperformed the TW Market which returned 27.4% over the past year.
Price Volatility
6534 volatility | |
---|---|
6534 Average Weekly Movement | 4.3% |
Chemicals Industry Average Movement | 3.4% |
Market Average Movement | 4.7% |
10% most volatile stocks in TW Market | 8.7% |
10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6534 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6534's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | n/a | Cho-Chun Huang | www.chbio.com |
CH Biotech R&D Co., Ltd., develops and sells biotech-based agrochemicals in Taiwan, the United States, Canada, Australia, Brazil, Argentina, Uruguay, Chile, and internationally. It offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd.
CH Biotech R&D Co., Ltd. Fundamentals Summary
6534 fundamental statistics | |
---|---|
Market cap | NT$8.53b |
Earnings (TTM) | NT$463.29m |
Revenue (TTM) | NT$1.51b |
18.4x
P/E Ratio5.6x
P/S RatioIs 6534 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6534 income statement (TTM) | |
---|---|
Revenue | NT$1.51b |
Cost of Revenue | NT$254.73m |
Gross Profit | NT$1.26b |
Other Expenses | NT$796.81m |
Earnings | NT$463.29m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
Earnings per share (EPS) | 4.51 |
Gross Margin | 83.18% |
Net Profit Margin | 30.58% |
Debt/Equity Ratio | 22.8% |
How did 6534 perform over the long term?
See historical performance and comparison